| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0004 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.002 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.003 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.004 |